Lpl Financial LLC Viking Therapeutics, Inc. Transaction History

Lpl Financial LLC

$218 Billion
Q3 2024

A detailed history of Lpl Financial LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 81,829 shares of VKTX stock, worth $4.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

81,829

Previous 57,503 42.3%

Holding current value

$4.3 Million

Previous $3.05 Million 69.95%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$49.84 - $70.47 $1.21 Million - $1.71 Million	24,326 Added 42.3%	81,829 $5.18 Million
Q2 2024 Aug 07, 2024	BUY	$47.39 - $80.2 $214,013 - $362,183	4,516 Added 8.52%	57,503 $3.05 Million
Q1 2024 May 10, 2024	BUY	$17.4 - $94.5 $58,324 - $316,764	3,352 Added 6.75%	52,987 $4.34 Million
Q4 2023 Feb 14, 2024	BUY	$9.24 - $19.64 $127,696 - $271,424	13,820 Added 38.59%	49,635 $923,000
Q3 2023 Nov 13, 2023	SELL	$10.92 - $16.0 $27,922 - $40,912	-2,557 Reduced 6.66%	35,815 $396,000
Q2 2023 Jul 31, 2023	BUY	$14.84 - $24.79 $85,582 - $142,963	5,767 Added 17.69%	38,372 $622,000
Q1 2023 May 10, 2023	SELL	$8.08 - $17.33 $89,243 - $191,409	-11,045 Reduced 25.3%	32,605 $542,000
Q4 2022 Feb 07, 2023	BUY	$2.72 - $9.4 $10,964 - $37,891	4,031 Added 10.17%	43,650 $410,000
Q3 2022 Nov 14, 2022	SELL	$2.55 - $3.89 $188 - $287	-74 Reduced 0.19%	39,619 $108,000
Q2 2022 Aug 12, 2022	BUY	$2.11 - $3.15 $28,573 - $42,657	13,542 Added 51.78%	39,693 $115,000
Q1 2022 May 16, 2022	SELL	$3.0 - $4.88 $4,095 - $6,661	-1,365 Reduced 4.96%	26,151 $78,000
Q4 2021 Feb 14, 2022	SELL	$4.6 - $6.72 $22,305 - $32,585	-4,849 Reduced 14.98%	27,516 $127,000
Q3 2021 Nov 15, 2021	BUY	$5.58 - $7.04 $30,522 - $38,508	5,470 Added 20.34%	32,365 $203,000
Q2 2021 Aug 13, 2021	BUY	$5.19 - $6.73 $7,785 - $10,095	1,500 Added 5.91%	26,895 $161,000
Q1 2021 May 14, 2021	BUY	$5.74 - $9.67 $63,140 - $106,370	11,000 Added 76.42%	25,395 $161,000
Q3 2020 Nov 09, 2020	SELL	$5.73 - $8.11 $22,920 - $32,439	-4,000 Reduced 21.75%	14,395 $84,000
Q2 2020 Aug 13, 2020	SELL	$4.35 - $8.08 $33,603 - $62,418	-7,725 Reduced 29.58%	18,395 $133,000
Q1 2020 May 14, 2020	BUY	$3.45 - $7.95 $29,152 - $67,177	8,450 Added 47.82%	26,120 $122,000
Q4 2019 Feb 14, 2020	SELL	$6.38 - $8.73 $23,593 - $32,283	-3,698 Reduced 17.31%	17,670 $142,000
Q3 2019 Nov 13, 2019	BUY	$6.55 - $8.6 $27,398 - $35,973	4,183 Added 24.34%	21,368 $147,000
Q2 2019 Aug 09, 2019	SELL	$7.67 - $10.63 $986,362 - $1.37 Million	-128,600 Reduced 88.21%	17,185 $143,000
Q1 2019 May 08, 2019	BUY	$7.58 - $9.94 $1.11 Million - $1.45 Million	145,785 New	145,785 $1.45 Million

Others Institutions Holding VKTX

# of Institutions

473

Shares Held

66.2M

Call Options Held

5.72M

Put Options Held

3.39M

View Full List

About Viking Therapeutics, Inc.

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $4.03B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

More about VKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account

Lpl Financial LLC Viking Therapeutics, Inc. Transaction History